Table 4.
Baseline blood test of participants.
| Mean ± S.E | Z | p | ||
|---|---|---|---|---|
| Intervention (n = 21) | Control (n = 20) | |||
| Hb (g/dL) | 13.30 ± 1.33 | 14.14 ± 1.26 | −1.880 | 0.060 |
| WBC (×103 cells/μL) | 5.82 ± 1.51 | 5.55 ± 1.80 | −0.574 | 0.566 |
| AST (U/L) | 28.39 ± 11.01 | 29.82 ± 20.80 | −0.013 | 0.990 |
| ALT (U/L) | 25.63 ± 17.68 | 24.36 ± 10.38 | −0.130 | 0.896 |
| HbA1c (%) | 5.67 ± 0.45 | 5.77 ± 0.45 | −0.694 | 0.487 |
| BUN (mg/dL) | 17.30 ± 4.55 | 17.09 ± 3.29 | −0.143 | 0.886 |
| LDL (mg/dL) | 103.40 ± 27.57 | 100.42 ± 30.96 | −0.469 | 0.639 |
| TG (mg/dL) | 129.71 ± 122.64 | 117.80 ± 72.70 | −0.404 | 0.686 |
ALT, alanine aminotransferase; AST, aspartate aminotransferase; BUN, blood urea nitrogen; Hb, hemoglobin; HbA1c, hemoglobin A1c; LDL, low-density lipoprotein; TG, triglyceride; WBC, white blood cell count.